相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models
Rajesh V. Dudhani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
D. Plachouras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme
Wing Yau et al.
JOURNAL OF INFECTION (2009)
Increased antimicrobial susceptibility profiles among polymyxin-resistant Acinetobacter baumannii clinical isolates
Rodrigo E. Mendes et al.
CLINICAL INFECTIOUS DISEASES (2008)
Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study
Nikolaos Markou et al.
CLINICAL THERAPEUTICS (2008)
Potential for underdosing and emergence of resistance in Acinetobacter baumannii during treatment with colistin
Miruna D. David et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Current concepts: Acinetobacter infection
L. Silvia Munoz-Price et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy
Joshua S. Hawley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro Pharmacokinetic/Pharmacodynamic model
Chun-Hong Tan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
Roxanne J. Owen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii
Jian Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The future should not look like the past
[Anonymous]
LANCET INFECTIOUS DISEASES (2006)
Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration
J Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate
J Li et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography
J Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis
J Li et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
The pharmacokinetics of colistin in patients with cystic fibrosis
MD Reed et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
分享论文
